Inhaled corticosteroids: higher risks of metabolic syndrome, BMI

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1647卷 / 1期
关键词：
D O I：
10.1007/s40278-017-28700-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [1] Inhaled corticosteroids: Benefits and risks
    Robinson, DS
    Geddes, DM
    JOURNAL OF ASTHMA, 1996, 33 (01) : 5 - 16
  • [2] INHALED CORTICOSTEROIDS - BENEFITS AND RISKS
    GEDDES, DM
    THORAX, 1992, 47 (06) : 404 - 407
  • [3] INHALED CORTICOSTEROIDS - BENEFITS AND RISKS
    SMITH, BJ
    THORAX, 1992, 47 (12) : 1084 - 1084
  • [4] Benefits and risks of inhaled corticosteroids
    Graft, DF
    ASTHMA: FROM GENES TO CLINICAL MANAGEMENT, 2003, : 39 - 46
  • [5] Weighing the benefits and risks of inhaled corticosteroids
    Varkey, Basil
    CURRENT OPINION IN PULMONARY MEDICINE, 2007, 13 (02) : 89 - 89
  • [6] Dose response to inhaled corticosteroids: Benefits and risks
    Lipworth, BJ
    Wilson, AM
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 19 (06) : 625 - 646
  • [7] Inhaled corticosteroids in COPD: quantifying risks and benefits
    Cates, Chris
    THORAX, 2013, 68 (06) : 499 - 500
  • [8] Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
    Suissa, Samy
    Kezouh, Abbas
    Ernst, Pierre
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (11): : 1001 - 1006
  • [9] Getting risks right on inhaled corticosteroids and adrenal insufficiency
    Watkins, Laura
    Soriano, Joan B.
    Mortimer, Kevin
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (01) : 9 - 11
  • [10] Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
    Henkle, Emily
    Curtis, Jeffrey R.
    Chen, Lang
    Chan, Benjamin
    Aksamit, Timothy R.
    Daley, Charles L.
    Griffith, David E.
    Winthrop, Kevin L.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
12345